Early phase insulin secretion is increased in subjects with normal fasting glucose and metabolic syndrome: A premature feature of beta-cell dysfunction

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 21, Issue 3, 2011, Pages 206-212

  Spadaro, L ^a   Alagona, C ^a   Palermo, F ^a   Piro, S ^a   Calanna, S ^a   Parrinello, G ^a   Purrello, F ^a   Rabuazzo, A M ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Early phase Insulin secretion; Hyperinsulinemia; Insulin secretion; Metabolic syndrome

Indexed keywords

C REACTIVE PROTEIN; INSULIN;

ADULT; ALGORITHM; ARTICLE; BLOOD; ECHOGRAPHY; FATTY LIVER; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; HOSPITALIZATION; HUMAN; HYPERINSULINISM; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; KINETICS; MALE; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PREVALENCE; SECRETION;

ADULT; ALGORITHMS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; DIABETES MELLITUS, TYPE 2; FATTY LIVER; FEMALE; GLUCOSE INTOLERANCE; HUMANS; HYPERINSULINISM; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; KINETICS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PREDIABETIC STATE; PREVALENCE; SEVERITY OF ILLNESS INDEX;

EID: 79951513195     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2009.09.003     Document Type: Article

References (23)

1. Wilson P.W., D'Agostino R.B., Parise H., Sullivan L., Meigs J.B. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005, 112:3066-3072.
2. Hanefeld M., Koehler C., Gallo S., Benke I., Ott P. Impact of the individual component of the metabolic syndrome and their different combinations on the prevalence of atherosclerotic vascular disease in type 2 diabetes: the Diabetes in Germany (DIG) study. Cardiovasc Diabetol 2007, 6:13.
3. Kotronen A., Yki-Jarvinen H. Fatty liver: a novel component of metabolic syndrome. Arterioscler Thromb Vasc Biol 2008 Jan, 28(1):27-38.
4. Eckel R.H., Grundy S.M., Zimmet P.Z. The metabolic syndrome. Lancet 2005, 365:1415-1428.
5. Weyer C., Bogardus C., Mott D.M., Pratley R.E. The natural hystory of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 1999, 104:787-794.
6. ATP III Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). J Am Med Assoc 2001, 285:2893-2898.
7. Expert Committee on the diagnosis and classification of diabetes mellitus Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003, 26:3160-3167.
8. Utzschneider K.M., Prigeon R.L., Tong J., Gerchman F., Carr D.B., Zraika S., et al. Within-subject variability of measures of beta cell function derived from a 2 h OGTT: implications for research studies. Diabetologia 2007, 50:2516-2525.
9. Matsuda M., DeFronzo R.A. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999 Sept, 22(9):1462-1470.
10. Gastaldelli A., Ferrannini E., Miyazaki Y., Matsuda M., Mari A., DeFronzo R.A. Thiazolidinediones improve beta-cell function in type 2 diabetic patients. Am J Physiol Endocrinol Metab 2007 Mar, 292(3):E871-E883. Epub 2006 Nov 14.
11. Kahn S.E., Prigeon R.L., McCulloch D.K., Boyko E.J., Bergman R.N., Schwartz M.W., et al. Quantification of the relationship between insulin sensitivity and b-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 1993 Nov, 42:1663-1672.
12. Retnakaran R., Shen S., Hanley A.J., Vuksan V., Hamilton J.K., Zinman B. Hyperbolic relationship between insulin secretion and sensitivity on oral glucose tolerance test. Obesity 2008 Aug, 16:1901-1906.
13. Spadaro L., Magliocco O., Spampinato D., Piro S., Oliveri C., Alagona C., et al. Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease. Dig Liver Dis 2008 Mar, 40(3):194-199.
14. Cnop M., Vidal J., Hull R.L., Utzschneider K.M., Carr D.B., Schraw T., et al. Progressive loss of beta-cell function leads to worsening glucose tolerance in first-degree relatives of subjects with type 2 diabetes. Diabetes Care 2007 Mar, 30(3):677.
15. Jensen C.C., Cnop M., Hull R.L., Fujiomoto W.Y., Kahn S.E. American Diabetes Association GENNID Study Group: beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S. Diabetes 2002 Jul, 51(7):2170-2178.
16. Ferrannini E., Natali A., Bell P., Cavallo-Perin P., Lalic N., Mingrone G. Insulin resistance and hypersecretion in obesity. European Group for the Study of Insulin Resistance (EGIR). J Clin Invest 1997 Sep 1, 100(5):1166-1173.
17. Arslanian S.A., Saad R., Lewy V., Danadian K., Janosky J. Hyperinsulinemia in african-american children: decreased insulin clearance and increased insulin secretion and its relationship to insulin sensitivity. Diabetes 2002 Oct, 51(10):3014-3019.
18. Carr R.D., Brand C.L., Bodvarsdottir T.B., Hansen J.B., Sturis J. NN414, a SUR1/Kir6.2-selective potassium channel opener, reduces blood glucose and improves glucose tolerance in the VDF Zucker rat. Diabetes 2003 Oct, 52(10):2513-2518.
19. Alemzadeh R., Tushaus K.M. Modulation of adipoinsular axis in prediabetic zucker diabetic fatty rats by diazoxide. Endocrinology 2004, 145(12):5476-5484.
20. Shanik M.H., Xu Y., Shrha J., Daukner R., Zick Y., Roth J. Insulin resistance and hyperinsulinemia: is hyperinsulinemia the cart or the horse?. Diabetes Care 2008 Feb, 31(Suppl. 2):S262-S268.
21. Aston-Mourney K., Proiett J., Morahan G., Andrikopoulos S. Too much of a good thing: why it is bad to stimulate the beta cell to secrete insulin. Diabetologia 2008 Feb, 51:540-545.
22. Hanley A.J.G., Wagenknecht L.E., D'Agostino R.B., Zinman B., Haffner S.M. Identification of subjects with insulin resistance and beta-cell dysfunction using alternative definitions of the metabolic syndrome. Diabetes 2003, 52:2740-2743.
23. Tushuizen M.E., Bunck M.C., Pouwels P.J., Bontemps S., Mari A., Diamant M. Lack of association of liver fat with model parameters of beta-cell function in men with impaired glucose tolerance and type 2 diabetes. Eur J Endocrinol 2008 Sept, 159(3):251-257.